Two patients with eating disorders treated by naltrexone

Neuroendocrinology Letters

Volumn 30, Issue 3, 2009, Pages 327-330

  Kmoch, Vladimir ^a   Papezova, Hana ^a   Yamamotova, Anna ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anorexia nervosa; Bulimia nervosa; Case reports; Endogenous opioids; Naltrexone

Indexed keywords

NALTREXONE; OPIATE;

ADULT; ANOREXIA NERVOSA; ARTICLE; CASE REPORT; CLINICAL PRACTICE; EATING DISORDER; EXHAUSTION; FEMALE; FOOD INTAKE; HUMAN; LONG TERM CARE; LOW DRUG DOSE; SLEEP DISORDER; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 70450225493     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brewerton TD, Lydiard RB, Laraia MT, Shook JE, Ballenger JC. (1992). CSF beta-endorphin and dynorphin in bulimia nervosa. Am J Psychiatry 149(8): 1086-1090
2. Chabane N, Leboyer M, Mouren-Simeoni MC (2000). Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry 9 (Suppl 1): 144-150.
3. Chatoor I, Herman BH, Hartzler J (1994). Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations. J Am Acad Child Adolesc Psychiatry 33: 748-752 (Pubitemid 24167033)
4. Cota D, Tschöp MH, Horvath TL, Levine AS (2005). Cannabinoids, opioids and eating behavior: The molecular face of hedonism? Brain Research Reviews S1: 85-107.
5. Davis C, Claridge G (1998). The eating disorder as addiction: A psychobiological perspective. Addict Behav. 23(4): 463-475 (Pubitemid 28311334)
6. Jonas JM, Gold MS (1987a). Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse. Adv Alcohol Subst Abuse 7: 29-37.
7. Jonas JM, Gold MS (1986). Naltrexone reverses bulimic symtoms. Lancet 1(8484): 807.
8. Jonas JM, Gold MS (1987b). Treatment of antidepressant-resistant bulimia with naltrexone. Int J Psychiatry in Medicine 16(4): 1986-1987
9. Jonas JM, Gold MS (1988). The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Research 24: 195-219
10. Marrazzi MA, Wroblewski JM, Kinzie J, Luby ED (1997). High-dose naltrexone and liver function safety. Am J Addict. 6(1): 21-29 (Pubitemid 27089039)
11. Rolls ET, McCabe C (2007). Enhanced affective brain representation of chocolate cravers vs. non-cravers. Eur J Neurosci. 26 (4): 1067-1076
12. Volkow ND, Wise RA (2005). How can drug addiction help us understand obesity? Nature Neuroscience 8: 555-560
13. de Zwaan M, Mitchell JE (1992). Opiate antagonists and eating behavior in humans: a review. J Clin Pharmacol. 32(12):1060-1072